| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
60,426 |
54,959 |
$2.33M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
6,468 |
6,268 |
$765K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,405 |
6,231 |
$625K |
| Z7502 |
|
14,298 |
14,037 |
$527K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
10,621 |
9,704 |
$484K |
| 80053 |
Comprehensive metabolic panel |
19,835 |
18,408 |
$263K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,034 |
12,252 |
$260K |
| 99199 |
Unlisted special service, procedure or report |
7,170 |
6,667 |
$256K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,925 |
3,746 |
$216K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,012 |
4,817 |
$210K |
| 71045 |
Radiologic examination, chest; single view |
15,507 |
14,842 |
$177K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,438 |
8,046 |
$172K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,720 |
21,780 |
$160K |
| J3490 |
Unclassified drugs |
23,400 |
11,465 |
$157K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,027 |
2,676 |
$149K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,701 |
2,632 |
$146K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,166 |
1,127 |
$135K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,087 |
2,050 |
$125K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,240 |
4,089 |
$125K |
| Z7610 |
|
8,697 |
5,496 |
$119K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,276 |
1,220 |
$87K |
| 0250 |
|
15,624 |
8,971 |
$75K |
| 84484 |
|
9,130 |
8,445 |
$73K |
| 80306 |
|
4,906 |
4,740 |
$73K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,600 |
1,568 |
$72K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,918 |
3,802 |
$65K |
| 0270 |
|
14,747 |
8,013 |
$63K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,877 |
1,813 |
$59K |
| 83690 |
|
9,527 |
9,034 |
$55K |
| 81001 |
|
15,059 |
14,489 |
$51K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,167 |
5,807 |
$47K |
| 0301 |
|
831 |
766 |
$44K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
415 |
383 |
$40K |
| 83735 |
|
6,937 |
6,599 |
$40K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,581 |
3,390 |
$38K |
| 84703 |
|
4,773 |
4,598 |
$37K |
| 83880 |
|
2,171 |
2,024 |
$36K |
| 90715 |
|
1,183 |
1,172 |
$36K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,626 |
6,318 |
$31K |
| 87040 |
|
1,867 |
1,816 |
$31K |
| 74018 |
|
1,073 |
1,055 |
$31K |
| 87088 |
|
7,881 |
7,610 |
$30K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
285 |
209 |
$26K |
| 73610 |
|
1,288 |
1,271 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,418 |
2,364 |
$26K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
135 |
132 |
$24K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
546 |
540 |
$23K |
| 73630 |
|
1,196 |
1,185 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,548 |
1,415 |
$22K |
| 0272 |
|
3,628 |
3,305 |
$21K |
| 73130 |
|
845 |
835 |
$20K |
| 70486 |
|
161 |
160 |
$19K |
| 73030 |
|
954 |
938 |
$19K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
419 |
414 |
$19K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,821 |
2,700 |
$17K |
| 72100 |
|
669 |
664 |
$16K |
| 0271 |
|
3,948 |
3,468 |
$16K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,292 |
1,992 |
$15K |
| 85730 |
|
2,934 |
2,849 |
$14K |
| 93971 |
|
175 |
169 |
$14K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,363 |
3,168 |
$13K |
| 83605 |
|
1,655 |
1,566 |
$13K |
| 82948 |
|
2,227 |
1,886 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,057 |
1,032 |
$12K |
| 85610 |
|
2,956 |
2,858 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
266 |
257 |
$12K |
| 94660 |
|
219 |
213 |
$10K |
| 73564 |
|
419 |
417 |
$10K |
| 82550 |
|
1,911 |
1,837 |
$9K |
| 76801 |
|
158 |
145 |
$9K |
| 85379 |
|
1,186 |
1,155 |
$8K |
| 0360 |
|
43 |
31 |
$8K |
| 87186 |
|
1,413 |
1,383 |
$8K |
| A4649 |
Surgical supply; miscellaneous |
1,857 |
941 |
$8K |
| J2060 |
Injection, lorazepam, 2 mg |
1,338 |
1,201 |
$8K |
| 73560 |
|
442 |
439 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,710 |
1,679 |
$7K |
| J1815 |
Injection, insulin, per 5 units |
536 |
463 |
$6K |
| 84702 |
|
469 |
423 |
$6K |
| 73110 |
|
278 |
277 |
$6K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,201 |
1,166 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
136 |
132 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
272 |
268 |
$5K |
| 72131 |
|
37 |
37 |
$5K |
| 85027 |
|
1,098 |
1,048 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,094 |
1,007 |
$5K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
27 |
27 |
$4K |
| 87071 |
|
1,387 |
1,358 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
29 |
27 |
$4K |
| 0710 |
|
52 |
48 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
117 |
115 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
802 |
789 |
$4K |
| 82248 |
|
1,057 |
971 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
746 |
739 |
$3K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
362 |
320 |
$3K |
| 87420 |
|
450 |
440 |
$3K |
| 81003 |
|
975 |
938 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
82 |
81 |
$2K |
| 82805 |
|
153 |
149 |
$2K |
| 94664 |
|
301 |
284 |
$2K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
435 |
362 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
104 |
103 |
$2K |
| 12001 |
|
69 |
68 |
$2K |
| 85007 |
|
932 |
895 |
$2K |
| 86901 |
|
508 |
495 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
224 |
210 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
443 |
426 |
$2K |
| 93970 |
|
15 |
15 |
$2K |
| 73080 |
|
90 |
90 |
$2K |
| 0762 |
|
41 |
39 |
$2K |
| 71010 |
|
73 |
56 |
$1K |
| 96367 |
|
39 |
38 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,223 |
1,082 |
$940.58 |
| J1630 |
Injection, haloperidol, up to 5 mg |
199 |
160 |
$803.95 |
| 29126 |
|
54 |
52 |
$779.83 |
| 36600 |
|
221 |
216 |
$774.60 |
| 82150 |
|
140 |
135 |
$706.41 |
| Z9725 |
|
16 |
16 |
$688.48 |
| 93041 |
|
112 |
100 |
$587.40 |
| 73140 |
|
77 |
77 |
$576.70 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,231 |
1,130 |
$576.36 |
| 73590 |
|
39 |
38 |
$533.16 |
| 86738 |
|
49 |
49 |
$374.77 |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
13 |
12 |
$370.80 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
113 |
88 |
$368.92 |
| 80061 |
Lipid panel |
76 |
71 |
$368.06 |
| 29131 |
|
27 |
27 |
$363.62 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
19 |
12 |
$322.88 |
| 0320 |
|
66 |
65 |
$286.24 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
28 |
28 |
$276.60 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
95 |
67 |
$271.55 |
| 86900 |
|
96 |
94 |
$258.67 |
| 76937 |
|
13 |
13 |
$239.32 |
| 72040 |
|
14 |
14 |
$233.80 |
| 80320 |
|
28 |
27 |
$220.50 |
| 99070 |
|
76 |
34 |
$191.74 |
| J1644 |
Injection, heparin sodium, per 1000 units |
75 |
38 |
$189.21 |
| J2704 |
Injection, propofol, 10 mg |
33 |
31 |
$169.13 |
| 29515 |
|
12 |
12 |
$142.32 |
| 73090 |
|
12 |
12 |
$127.27 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
15 |
12 |
$84.64 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
33 |
30 |
$80.36 |
| 96376 |
|
14 |
13 |
$78.90 |
| J7050 |
Infusion, normal saline solution, 250 cc |
16 |
15 |
$76.64 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
15 |
$59.75 |
| 82009 |
|
17 |
14 |
$54.70 |
| 87070 |
|
13 |
13 |
$49.99 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14 |
14 |
$48.86 |
| 86140 |
|
16 |
14 |
$43.96 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
35 |
30 |
$3.86 |
| A0425 |
Ground mileage, per statute mile |
201 |
179 |
$0.00 |
| 0637 |
|
189 |
56 |
$0.00 |
| A0424 |
Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review) |
46 |
42 |
$0.00 |
| E0601 |
Continuous positive airway pressure (cpap) device |
83 |
83 |
$0.00 |
| 0760 |
|
18 |
18 |
$0.00 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
50 |
49 |
$0.00 |
| A0398 |
Als routine disposable supplies |
31 |
30 |
$0.00 |
| E0562 |
Humidifier, heated, used with positive airway pressure device |
124 |
124 |
$0.00 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
71 |
67 |
$0.00 |
| A0999 |
Unlisted ambulance service |
30 |
29 |
$0.00 |